Steward Partners Investment Advisory, LLC Bridge Bio Pharma, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 200 shares of BBIO stock, worth $5,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$5,122% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
176MCall Options Held
8.64MPut Options Held
2.84M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$795 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$643 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$360 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$319 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$155 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.8B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...